Page-1199545Page-193840Page-178433Page-158681Page-1400232474Page-217365Page-128240Page-178420Page-225858Page-169489Related: Stocks, Markets, Mutual Fund Center, Private Capital U.S. RESEARCH ROUNDUP-Goldman Sachs, Yahoo, Terex
Sept 9 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Medidata Solutions, Keycorp and Yahoo, on Wednesday. HIGHLIGHTS * Goldman Sachs : BofA Merrill raises to buy from neutral * Tetraphase Pharmaceuticals : Nomura, Brean, Stifel cuts rating on the stock * Terex Corp : JP Morgan cuts to underweight from neutral * Yahoo Barclays, Nomura, Mizuho, others cut target price * Ciena Corp : RBC raises to outperform from sector perform Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order. * Aerie Pharmaceuticals Inc : JMP Securities starts with market outperform rating * Aerie Pharmaceuticals Inc : JMP Securities starts with price target of $39 * Affiliated Managers Group Inc : Deutsche Bank cuts price target to $248 from $256 * Aimco : Barclays raises to overweight from equal weight * Aimco : Barclays raises target price by $3 to $43 * Alder Biopharmaceuticals Inc : Jefferies starts with buy rating; price target $72 * Alibaba Group Holding Ltd : Cantor cuts target price to $88 from $95; rating buy * Akebia Therapeutics Inc : Brean Capital raises target price to $26 from $18; buy * Akorn Inc : JMP Securities starts with market perform rating * Anacor Pharmaceuticals Inc : JMP Securities starts with market outperform rating * Anacor Pharmaceuticals Inc : JMP Securities starts with $173 price target * Apollo Global Management LLC : Deutsche Bank cuts price target to $19 from $21 * Arris Group Inc : UBS raises price target to $34 from $31 * Arris Group Inc : UBS raises to buy from neutral * Atara Biotherapeutics Inc : Canaccord Genuity starts with buy, $80 price target * Baidu Inc : Deutsche Bank cuts target price to $170 from $206; rating hold * Biocryst Pharmaceuticals Inc : Jefferies starts with hold rating; price target $12 * Biogen Inc : Jefferies starts with buy; target price $348 * Blackstone Group LP : Deutsche Bank cuts price target to $44 from $48 * BNY Mellon : Deutsche Bank raises to buy from hold * BNY Mellon : Deutsche Bank cuts price target to $47 from $48 * Boston Properties Inc : Stifel raises to buy from hold * BreitBurn Energy Partners LP : UBS cuts to sell from neutral * Carlyle Group LP : Deutsche Bank cuts price target to $27 from $30 * Casey's General Stores : RBC raises target price to $111 from $109; sector perform * CBOE Holdings : KBW raises price target to $67 from $65 * CBOE Holdings Inc : Deutsche Bank raises price target to $63 from $60 * Charles Schwab Corp : Deutsche Bank cuts target price to $39 from $43 * Ciena Corp : RBC raises to outperform from sector perform * Ciena Corp : RBC raises price target to $28 from $26 * Concordia Healthcare Corp : Canaccord Genuity raises target to $100 from $95 * Comerica Inc : BMO Capital starts with underperform rating; target price of $44 * Continental Resources : Wunderlich cuts target price to $32 from $35; rating hold * Danaher Corp : Sterne Agee CRT starts with neutral rating; target price of $87 * Danaher Corp : RBC cuts price target to $91 from $93; rating sector perform * Dave & Buster's : Jefferies raises price target to $45 from $41; rating buy * Dave & Buster's : Stifel raises target price to $45 from $42; rating buy * Diamondback Energy Inc : Euro Pacific Capital starts with buy; $90 target price * Domino's Pizza Inc : Goldman Sachs raises to buy from neutral * E*TRADE Financial : Evercore ISI raises to buy from hold * E*TRADE Financial : Barclays raises target price to $35 from $32;rating overweight * E*TRADE Financial Corp : Deutsche Bank cuts price target to $32 from $34 * Eaton Vance Corp : RBC cuts target price to $46 from $49; rating outperform * Emerson Electric : Sterne Agee CRT starts with neutral rating; target price of $44 * Enlink Midstream LLC : UBS raises to buy * Exfo Inc : Northland Capital starts with outperform; $4 target price * Exone Co : Imperial Capital starts with in-line rating; $8 price target * Faro Technologies : Sterne Agee CRT starts with neutral; target price of $39 * Fifth Third Bancorp : BMO Capital starts with outperform rating; target price $23 * Financial Engines Inc : Jefferies starts with buy rating; price target $41 * Finisar Corp : RBC cuts to sector perform from outperform * Finisar Corp : RBC cuts price target to $17 from $21 * Flex : UBS Analyst Steven Milunovich assumes coverage * Flex : UBS raises to buy from neutral; target price to $13 from $12 * Flexion Therapeutics Inc : Needham cuts target price to $28 from $31; rating buy * Forward Pharma : Leerink cuts price target to $46 from $53; rating outperform * Forward Pharma A/S : Jefferies cuts price target to $42 from $43; rating buy * Franklin Resources Inc : Deutsche Bank raises to buy from hold * Franklin Resources Inc : Deutsche Bank cuts price target to $46 from $48 * General Finance : D. A. Davidson cuts price target to $6 from $8; rating buy * Genesco : Susquehanna cuts target price to $72 from $77; rating positive * Goldman Sachs : BofA Merrill raises to buy from neutral * Highwoods Properties Inc : SunTrust Robinson Humphrey raises to buy from neutral * Horizon Pharma Plc : JMP Securities resumes coverage with market outperform rating * Horizon Pharma Plc : JMP Securities resumes coverage with price target of $39 * Huntington Bancshares : BMO Capital starts with market perform; target price $12 * ICE : Deutsche Bank raises price target to $272 from $257 * IGI Laboratories Inc : JMP Securities starts with market perform rating * IMAX Corp : MKM Partners cuts price target to $40 from $50; rating buy * IMAX Corp : Stifel cuts target price to $40 from $45; rating buy * Immune Design : Jefferies assumes coverage with buy rating; price target $30 * IMS Health : Barclays raises target price to $36 from $34; rating overweight * Intelsat : Jefferies cuts target price to $10; rating hold * Intuit Inc : UBS cuts target price to $114 from $117; rating buy * Invesco Ltd : Deutsche Bank cuts price target to $43 from $45 * Jabil Circuit Inc : UBS assumes coverage with neutral; price target $21 * Keycorp : BMO Capital starts with outperform rating; target price of $16 * KKR & Co